Our methods enabled us to assess desirability for an at-home therapeutic, and to determine the cognitive and emotional resonance with this new therapy. We uncovered the individual and cultural barriers that need to be overcome for this product to be introduced successfully, used regularly, and integrated into real people’s everyday lives.
Through our highly effective comparative anchoring method, we determined price and insurance thresholds that informed cost and viability. Thus, we paved a path to market access with pricing, merchandising, and partnership recommendations to position the product for maximum adoption and treatment at scale. We further built a pathway for the service and experience design strategy, along with marketing and advertising messaging. Nesos has just secured over $15m in funding, completed more affirming clinical research, and is pursuing FDA approval for this device to treat rheumatoid arthritis, with more conditions likely to be approved in the years ahead.